The non-classical export routes: FGF1 and IL-1α point the way

Journal of Cell Science

Volumn 116, Issue 24, 2003, Pages 4871-4881

  Prudovsky, Igor ^a   Mandinova, Anna ^a   Soldi, Raffaella ^a   Bagala, Cinzia ^a   Graziani, Irene ^a   Landriscina, Matteo ^b   Tarantini, Francesca ^c   Duarte, Maria ^a   Bellum, Stephen ^a   Doherty, Holly ^a   Maciag, Thomas ^a  

^a Maine Medical Center Research Institute   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Copper; FGF1; Fibroblast growth factor 1; IL 1 ; Interleukin 1 ; Non classical; Release; S100A13; Synaptotagmin 1

Indexed keywords

ANGIOGENIC FACTOR; CHELATING AGENT; COLONY STIMULATING FACTOR 1; COPPER ION; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; POLYPEPTIDE; PROTEIN S 100; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

AMINO TERMINAL SEQUENCE; CARCINOGENESIS; CELL ACTIVITY; CELL HYPOXIA; COMPLEX FORMATION; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HEAT SHOCK; HUMAN; LEUKEMIA CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TRANSPORT; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL HYPOXIA; CELL MEMBRANE; COPPER; ENDOPLASMIC RETICULUM; FIBROBLAST GROWTH FACTOR 1; HUMANS; INTERLEUKIN-1; MEMBRANE FLUIDITY; MODELS, STRUCTURAL; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT; S100 PROTEINS;

EID: 9144267257     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00872     Document Type: Review

References (139)

1. Ananyeva, N. M., Tijurmin, A. V., Berliner, J. A., Chisolm, G. M., Liau, G., Winkles, J. A. and Haudenschild, C. C. (1997). Oxidized LDL mediates the release of fibroblast growth factor-1. Arterioscler Thromb. Vasc. Biol. 17, 445-453.
2. Ancellin, N., Colmont, C., Su, J., Li, Q., Mittereder, N., Chae, S. S., Stefansson, S., Liau, G. and Hla, T. (2002). Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J. Biol. Chem. 277, 6667-6675.
3. Andrei, C., Dazzi, C., Lotti, L., Torrisi, M. R., Chimini, G. and Rubartelli, A. (1999). The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell 10, 1463-1475.
4. Angelini, G., Gardella, S., Ardy, M., Ciriolo, M. R., Filomeni, G., di Trapani, G., Clarke, F., Sitia, R. and Rubartelli, A. (2002). Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. USA 99, 1491-1496.
5. Arai, M. and Kuwajima, K. (2000). Role of the molten globule state in protein folding. Adv. Protein Chem. 53, 209-282.
6. Aumuller, G., Wilhelm, B. and Seitz, J. (1999). Apocrine secretion - fact or artifact? Anat. Anz. 181, 437-446.
7. Baldwin, A. S., Jr (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
8. Barnes, J. A. and Gomes, A. V. (2002). Proteolytic signals in the primary structure of annexins. Mol. Cell. Biochem. 231, 1-7.
9. Beuscher, H. U., Nickells, M. W. and Colten, H. R. (1988). The precursor of interleukin-1 alpha is phosphorylated at residue serine 90. J. Biol. Chem. 263, 4023-4028.
10. Blobel, G. (1995). Unidirectional and bidirectional protein traffic across membranes. Cold Spring Harb. Symp. Quant. Biol. 60, 1-10.
11. Blobel, G. (2000). Protein targeting (Nobel lecture). Chembiochem 1, 86-102.
12. Breen, E. C., Fu, Z. and Normand, H. (1999). Calcyclin gene expression is increased by mechanical strain in fibroblasts and lung. Am. J. Respir. Cell Mol. Biol. 21, 746-752.
13. Brewer, G. J. (2001). Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease. Exp. Biol. Med. 226, 665-673.
14. Brewer, G. J., Dick, R. D., Grover, D. K., LeClaire, V., Tseng, M., Wicha, M., Pienta, K., Redman, B. G., Jahan, T., Sondak, V. K. et al. (2000). Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clin. Cancer Res. 6, 1-10.
15. Brogi, E., Winkles, J. A.., Underwood, R., Clinton, S. K., Alberts, G. F. and Libby, P. (1993). Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. J. Clin. Invest. 92, 2408-2418.
16. Burgess, W. H., Mehlman, T., Friesel, R., Johnson, W. V. and Maciag, T. (1985). Multiple forms of endothelial cell growth factor. Rapid isolation and biological and chemical characterization. J. Biol. Chem. 260, 11389-11392.
17. Bychkova, V. E., Pain, R. H. and Ptitsyn, O. B. (1988). The 'molten globule' state is involved in the translocation of proteins across membranes? FEBS Lett. 238, 231-234.
18. Chang, H. C., Samaniego, E, Nair, B. C., Buonaguro, L. and Ensoli, B. (1997). HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11, 1421-1431.
19. Chapman, L. P., Epton, M. J., Buckingham, J. C., Morris, J. F. and Christian, H. C. (2003). Evidence for a role of the adenosine 5′-triphosphate-binding cassette transporter A1 in the externalization of annexin I from pituitary folliculo-stellate cells. Endocrinology 144, 1062-1073.
20. Chen, X. S. and Funk, C. D. (2001). The N-terminal 'beta-barrel' domain of 5-lipoxygenase is essential for nuclear membrane translocation. J. Biol. Chem. 276, 811-818.
21. Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y. et al. (2001). Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676.
22. Choi, J., Chang, J. S., Song, M. S., Ahn, B. Y., Park, Y., Lim, D. S. and Han, Y. S. (2003). Association of hepatitis B virus polymerase with promyelocytic leukemia nuclear bodies mediated by the S100 family protein p11. Biochem. Biophys. Res. Commun. 305, 1049-1056.
23. Coulier, F., Pontarotti, P., Roubin, R., Hartung, H., Goldfarb, M. and Birnbaum, D. (1997). Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families. J. Mol. Evol. 44, 43-56.
24. Cox, C., Teknos, T. N., Barrios, M., Brewer, G. J., Dick, R. D. and Merajver, S. D. (2001). The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. Laryngoscope 111, 696-701.
25. Dahl, J. P., Binda, A., Canfield, V. A. and Levenson, R. (2000). Participation of Na,K-ATPase in FGF-2 secretion: rescue of ouabain-inhibitable FGF-2 secretion by ouabain-resistant Na,K-ATPase alpha subunits. Biochemistry 39, 14877-14883.
26. Denny, P. W., Gokool, S., Russell, D. G., Field, M. C. and Smith, D. F. (2000). Acylation-dependent protein export in Leishmania. J. Biol. Chem. 275, 11017-11025.
27. Dinarello, C. A. (1992). The biology of interleukin-1. Chem. Immunol. 51, 1-32.
28. Dinarello, C. A. (1996). Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.
29. Dinarello, C. A. (1998). Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 16, 457-499.
30. Du, X. J., Cole, T. J., Tenis, N., Gao, X. M., Kontgen, F., Kemp, B. E. and Heierhorst, J. (2002). Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice. Mol. Cell. Biol. 22, 2821-2829.
31. Duarte, W. R., Mikuni-Takagaki, Y., Kawase, T., Limura, T., Oida, S., Ohya, K., Takenaga, K., Ishikawa, L. and Kasugai, S. (1999). Effects of mechanical stress on the mRNA expression of S100A4 and cytoskeletal components by periodontal ligament cells. J. Med. Dent. Sci. 46, 117-122.
32. Dutch, R. E., Jardetzky, T. S. and Lamb, R. A. (2000). Virus membrane fusion proteins: biological machines that undergo a metamorphosis. Biosci. Rep. 20, 597-612.
33. Elliott, G. and O'Hare, P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223-233.
34. Endo, T., Yamamoto, H. and Esaki, M. (2003). Functional cooperation and separation of translocators in protein import into mitochondria, the double-membrane bounded organelles. J. Cell Sci. 116, 3259-3267.
35. Engleka, K. A. and Maciag, T. (1992). Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation. J. Biol. Chem. 267, 11307-11315.
36. Engling, A., Backhaus, R., Stegmayer, C., Zehe, C., Seelenmeyer, C., Kehlenbach, A., Schwappach, B., Wegehingel, S. and Nickel, W. (2002). Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells. J. Cell Sci. 115, 3619-3631.
37. Fernandez, I., Arac, D., Ubach, J., Gerber, S. H., Shin, O., Gao, Y., Anderson, R. G., Sudhof, T. C. and Rizo, J. (2001). Three-dimensional structure of the synaptotagmin 1 C2B-domain: synaptotagmin 1 as a phospholipid binding machine. Neuron 32, 1057-1069.
38. Finney, L. A. and O'Halloran, T. V. (2003). Transition metal speciation in the cell: insights from the chemistry of metal ion receptors. Science 300, 931-936.
39. Florkiewicz, R. Z., Anchin, J. and Baird, A. (1998). The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase. J. Biol. Chem. 273, 544-551.
40. Florkiewicz, R. Z., Majack, R. A., Buechler, R. D. and Florkiewicz, E. (1995). Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway. J. Cell Physiol. 162, 388-399.
41. Folkman, J. (2002). Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29, 15-18.
42. Forough, R., Zhan, X., MacPhee, M., Friedman, S., Engleka, K. A., Sayers, T., Wiltrout, R. H. and Maciag, T. (1993). Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1. J. Biol. Chem. 268, 2960-2968.
43. Friesel, R. and Maciag, T. (1999). Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling. Thromb. Haemost. 82, 748-754.
44. Furutani, Y., Notake, M., Fukui, T., Ohue, M., Nomura, H., Yamada, M. and Nakamura, S. (1986). Complete nucleotide sequence of the gene for human interleukin 1 alpha. Nucleic Acids Res. 14, 3167-3179.
45. Gardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E. and Rubartelli, A. (2002). The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3, 995-1001.
46. Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., Donnelly, R. J., Jacobsen, J. S., Vitek, M. P. and Gajdusek, D. C. (1989). Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86, 7606-7610.
47. Goll, D. E., Thompson, V. F., Li, H., Wei, W. and Cong, J. (2003). The Calpain System. Physiol. Rev. 83, 731-801.
48. Gordon, D., Dancis, A. and Pain, D. (2000). Mechanisms of mitochodrial protein import. Essays Biochem. 36, 61-73.
49. Graves, B. J., Hatada, M. H., Hendrickson, W. A., Miller, J. K., Madison, V. S. and Satow, Y. (1990). Structure of interleukin 1 alpha at 2.7-A resolution. Biochemistry 29, 2679-2684.
50. Gullino, P. M. (1983). Angiogenesis and neoplastic growth. Prog. Clin. Biol. Res. 132C, 101-107.
51. Hajjar, K. A., Jacovina, A. T. and Chacko, J. (1994). An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J. Biol. Chem. 269, 21191-21197.
52. Hajjar, K. A., Mauri, L., Jacovina, A. T., Zhong, F., Mirza, U. A., Padovan, J. C. and Chait, B. T. (1998). Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J. Biol. Chem. 273, 9987-9993.
53. Hannan, G. N. and McAuslan, B. R. (1982). Modulation of synthesis of specific proteins in endothelial cells by copper, cadmium, and disulfiram: an early response to an angiogenic inducer of cell migration. J. Cell. Physiol. 111, 207-212.
54. Heizmann, C. W. and Cox, J. A. (1998). New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family. Biometals 11, 383-397.
55. Heizmann, C. W., Fritz, G. and Schafer, B. W. (2002). S100 proteins: structure, functions and pathology. Front. Biosci. 7, d1356-d1368.
56. Heuck, A. P., Hotze, E. M., Tweten, R. K. and Johnson, A. E. (2000). Mechanism of membrane insertion of a multimeric beta-barrel protein: perfringolysin O creates a pore using ordered and coupled conformational changes. Mol. Cell 6, 1233-1242.
57. Holroyd, C. and Erdmann, R. (2001). Protein translocation machineries of peroxisomes. FEBS Lett. 501, 6-10.
58. Hoyaux, D., Decaestecker, C., Heizmann, C. W., Vogl, T., Schafer, B. W., Salmon, I., Kiss, R. and Pochet, R. (2000). S100 proteins in Corpora amylacea from normal human brain. Brain Res. 867, 280-288.
59. Hsieh, H. L., Schafer, B. W., Cox, J. A. and Heizmann, C. W. (2002). S100A13 and S100A6 exhibit distinct translocation pathways in endothelial cells. J. Cell Sci. 115, 3149-3158.
60. Hughes, R. C. (1999). Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim. Biophys. Acta 1473, 172-185.
61. Jackson, A., Friedman, S., Zhan, X., Engleka, K. A., Forough, R. and Maciag, T. (1992). Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 89, 10691-10695.
62. Joliot, A., Maizel, A., Rosenberg, D., Trembleau, A., Dupas, S., Volovitch, M. and Prochiantz, A. (1998). Identification of a signal sequence necessary for the unconventional secretion of Engrailed homeoprotein. Curr. Biol. 8, 856-863.
63. Kim, J. and Hajjar, K. A. (2002). Annexin II: a plasminogen-plasminogen activator co-receptor. Front. Biosci. 7, d341-d348.
64. Kobayashi, Y., Oppenheim, J. J. and Matsushima, K. (1990). Calcium-dependent binding of phosphorylated human pre interleukin 1 alpha to phospholipids. J. Biochem. 107, 666-670.
65. Kucharczak, J., Pannequin, J., Camby, I., Decaestecker, C., Kiss, R. and Martinez, J. (2001). Gastrin induces over-expression of genes involved in human U373 glioblastoma cell migration. Oncogene 20, 7021-7028.
66. Lam, A. G., Koppal, T., Akama, K. T., Guo, L., Craft, J. M., Samy, B., Schavocky, J. P., Watterson, D. M. and van Eldik, L. J. (2001). Mechanism of glial activation by S100B: involvement of the transcription factor NFkappaB. Neurobiol. Aging 22, 765-772.
67. Landriscina, M., Prudovsky, I., Carreira, C. M., Soldi, R., Tarantini, F. and Maciag, T. (2000). Amlexanox reversibly inhibits cell migration and proliferation and induces the Src-dependent disassembly of actin stress fibers in vitro. J. Biol. Chem. 275, 32753-32762.
68. Landriscina, M., Soldi, R., Bagala, C., Micucci, I., Bellum, S., Tarantini, F., Prudovsky, I. and Maciag, T. (2001a). S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro. J. Biol. Chem. 276, 22544-22552.
69. Landriscina, M., Bagala, C., Mandinova, A., Soldi, R., Micucci, I., Bellum, S., Prudovsky, I. and Maciag, T. (2001b). Copper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stress. J. Biol. Chem. 276, 25549-25557.
70. LaVallee, T. M., Tarantini, F., Gamble, S., Carreira, C. M., Jackson, A. and Maciag, T. (1998). Synaptotagmin-1 is required for fibroblast growth factor-1 release. J. Biol. Chem. 273, 22217-22223.
71. Lecellier, C. H., Vermeulen, W., Bachelerie, F., Giron, M. L. and Saib, A. (2002). Intra- and intercellular trafficking of the foamy virus auxiliary bet protein. J. Virol. 76, 3388-3394.
72. Lee, J., Pena, M. M., Nose, Y. and Thiele, D. J. (2002). Biochemical characterization of the human copper transporter Ctr1. J. Biol. Chem. 277, 4380-4387.
73. Lindstedt, R., Apodaca, G., Barondes, S. H., Mostov, K. E. and Leffler, H. (1993). Apical secretion of a cytosolic protein by Madin-Darby canine kidney cells. Evidence for polarized release of an endogenous lectin by a nonclassical secretory pathway. J. Biol. Chem. 268, 11750-11757.
74. Lomedico, P. T., Gubler, U., Hellmann, C. P., Dukovich, M., Giri, J. G., Pan, Y. C., Collier, K., Semionow, R., Chua, A. O. and Mizel, S. B. (1984). Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312, 458-462.
75. Lozano, R. M., Pineda-Lucena, A., Gonzalez, C., Angeles Jimenez, M., Cuevas, P., Redondo-Horcajo, M., Sanz, J. M., Rico, M. and Gimenez-Gallego, G. (2000). 1HNMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor. Biochemistry 39, 4982-4993.
76. Mach, H. and Middaugh, C. R. (1995). Interaction of partially structured states of acidic fibroblast growth factor with phospholipid membranes. Biochemistry 34, 9913-9920.
77. Maciag, T., Cerundolo, J., Ilsley, S., Kelley, P. R. and Forand, R. (1979). An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc. Natl. Acad. Sci. USA 76, 5674-5678.
78. Maciag, T., Hoover, G. A. and Weinstein, R. (1982). High and low molecular weight forms of endothelial cell growth factor. J. Biol. Chem. 257, 5333-5336.
79. Maier, J. A., Voulalas, P., Roeder, D. and Maciag, T. (1990). Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science 249, 1570-1574.
80. Maini, R. N. and Taylor, P. C. (2000). Anti-cytokine therapy for rheumatoid arthritis. Annu. Rev. Med. 51, 207-229.
81. Maizel, A., Bensaude, O., Prochiantz, A. and Joliot, A. (1999). A short region of its homeodomain is necessary for engrailed nuclear export and secretion. Development 126, 3183-3190.
82. Maizel, A., Tassetto, M., Filhol, O., Cochet, C., Prochiantz, A. and Joliot, A. (2002). Engrailed homeoprotein secretion is a regulated process. Development 129, 3545-3553.
83. Mandinov, L., Mandinova, A., Kyurkchiev, S., Kyurkchiev, D., Kehayov, I., Kolev, V., Soldi, R., Bagala, C., de Muinck, E. D., Lindner, V. et al. (2003). Copper chelation represses the vascular response to injury. Proc. Natl. Acad. Sci. USA 100, 6700-6705.
84. Mandinova, A., Atar, D., Schafer, B. W., Spiess, M., Aebi, U. and Heizmann, C. W. (1998). Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J. Cell Sci. 111, 2043-2054.
85. Mandinova, A., Soldi, R., Graziani, I., Bagala, C., Bellum, S., Landriscina, M., Tarantini, F., Prudovsky, I. and Maciag, T. (2003). S100A13 mediates the copper-dependent stress-induced release of IL-1alpha from both human U937 and murine NIH 3T3 cells. J. Cell Sci. 116, 2687-2696.
86. Marqueze, B., Berton, F. and Seagar, M. (2000). Synaptotagmins in membrane traffic: which vesicles do the tagmins tag? Biochimie 82, 409-420.
87. McMahon, G. A., Garfinkel, S., Prudovsky, I., Hu, X. and Maciag, T. (1997). Intracellular precursor interleukin (IL)-1alpha, but not mature IL-1alpha, is able to regulate human endothelial cell migration in vitro. J. Biol. Chem. 272, 28202-28205.
88. Migheli, A., Cordera, S., Bendotti, C., Atzori, C., Piva, R. and Schiffer, D. (1999). S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 261, 25-28.
89. Mignatti, P., Morimoto, T. and Rifkin, D. B. (1992). Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J. Cell Physiol. 151, 81-93.
90. Misumi, Y., Miki, K., Takatsuki, A., Tamura, G. and Ikehara, Y. (1986). Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J. Biol. Chem. 261, 11398-11403.
91. Montoya, M. and Gouaux, E. (2003). Beta-barrel membrane protein folding and structure viewed through the lens of alpha-hemolysin. Biochim. Biophys. Acta 1609, 19-27.
92. Mouta Carreira, C., LaVallee, T., Tarantini, F., Jackson, A., Lathrop, J. T., Hampton, B., Burgess, W. H. and Maciag, T. (1998). S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro. J. Biol. Chem. 273, 22224-22231.
93. Mouta Carreira, C. M., Nasser, S. M., di Tomaso, E., Padera, T. P., Boucher, Y., Tomarev, S. I. and Jain, R. K. (2001). LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 61, 8079-8084.
94. Nickel, W. (2003). The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270, 2109-2119.
95. Oku, N., Saito, N., Okada, S., Watanabe, N. and Kobayashi, Y. (1995). Permeability change of liposomal membrane induced by interleukin-1 alpha. J. Biochem. Tokyo 118, 832-835.
96. Oyama, Y., Shishibori, T., Yamashita, K., Naya, T., Nakagiri, S., Maeta, H. and Kobayashi, R. (1997). Two distinct anti-allergic drugs, amlexanox and cromolyn, bind to the same kinds of calcium binding proteins, except calmodulin, in bovine lung extract. Biochem. Biophys. Res. Commun. 240, 341-347.
97. Pan, Q., Kleer, C. G., van Golen, K. L., Irani, J., Bottema, K. M., Bias, C., de Carvalho, M., Mesri, E. A., Robins, D. M., Dick, R. D. et al. (2002). Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 62, 4854-4859.
98. Passalacqua, M., Zicca, A., Sparatore, B., Patrone, M., Melloni, E. and Pontremoli, S. (1997). Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation. FEBS Lett. 400, 275-279.
99. Passalacqua, M., Patrone, M., Picotti, G. B., del Rio, M., Sparatore, B., Melloni, E. and Pontremoli, S. (1998). Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience 82, 1021-1028.
100. Peterson, E., Sutherland, M., Nesheim, M., Pryzdial, E. (2003). Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2. J. Cell Sci. 116, 2399-2408.
101. Pomorski, T., Hrafnsdottir, S., Devaux, P., van Meer, G. (2001). Lipid distribution and transport across cellular membranes. Semin. Cell Dev. Biol, 12, 139-148.
102. Prudovsky, I., Bagala, C., Tarantini, F., Mandinova, A., Soldi, R., Bellum, S. and Maciag, T. (2002). The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export. J. Cell Biol. 158, 201-208.
103. Ptitsyn, O. B. (1995). Molten globule and protein folding. Adv. Protein Chem. 47, 83-229.
104. Rae, T. D., Schmidt, P. J., Pufahl, R. A., Culotta, V. C. and O'Halloran, T. V. (1999). Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284, 805-808.
105. Raju, K. S., Alessandri, G., Ziche, M. and Gullino, P. M. (1982). Ceruloplasmin, copper ions, and angiogenesis. J. Natl. Cancer Inst. 69, 1183-1188.
106. Rogers, S. L. and Gelfand, V. I. (2000). Membrane trafficking, organelle transport, and the cytoskeleton. Curr. Opin. Cell Biol. 12, 57-62.
107. Rosengart, T. K., Johnson, W. V., Friesel, R., Clark, R. and Maciag, T. (1988). Heparin protects heparin-bindiing growth factor-I from proteolytic inactivation in vitro. Biochem. Biophys. Res. Commun. 152, 432-440.
108. Rubartelli, A., Cozzolino, F., Talio, M. and Sitia, R. (1990). A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 9, 1503-1510.
109. Rubartelli, A., Bajetto, A., Allavena, G., Wollman, E. and Sitia, R. (1992). Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267, 24161-24164.
110. Rubartelli, A., Bonifaci, N. and Sitia, R. (1995). High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res. 55, 675-680.
111. Sano, H., Forough, R., Maier, J. A., Case, J. P., Jackson, A., Engleka, K., Maciag, T. and Wilder, R. L. (1990). Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J. Cell Biol. 110, 1417-1426.
112. Sano, H., Hla, T., Maier, J. A., Crofford, L. J., Case, J. P., Maciag, T. and Wilder, R. L. (1992). In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J. Clin. Invest. 89, 97-108.
113. Sanz, J. M., Jimenez, M. A. and Gimenez-Gallego, G. (2002). Hints of nonhierarchical folding of acidic fibroblast growth factor. Biochemistry 41, 1923-1933.
114. Sato, S., Burdett, I. and Hughes, R. C. (1993). Secretion of the baby hamster kidney 30-kDa galactose-binding lectin from polarized and nonpolarized cells: a pathway independent of the endoplasmic reticulum-Golgi complex. Exp. Cell. Res. 207, 8-18.
115. Shi, J., Friedman, S. and Maciag, T. (1997). A carboxyl-terminal domain in fibroblast growth factor (FGF)-2 inhibits FGF-1 release in response to heat shock in vitro. J. Biol. Chem. 272, 1142-1147.
116. Shin, J. T., Opalenik, S. R., Wehby, J. N., Mahesh, V. K., Jackson, A., Tarantini, F., Maciag, T. and Thompson, J. A. (1996). Serum-starvation induces the extracellular appearance of FGF-1. Biochim. Biophys. Acta 1312, 27-38.
117. Sims, P. J. and Wiedmer, T. (2001). Unraveling the mysteries of phospholipid scrambling. Thromb. Haemost. 86, 266-275.
118. Sloan, I. S., Horowitz, P. M. and Chirgwin, J. M. (1994). Rapid secretion by a nonclassical pathway of overexpressed mammalian mitochondrial rhodanese. J. Biol. Chem. 269, 27625-27630.
119. Sparatore, B., Passalacqua, M., Patrone, M., Melloni, E. and Pontremoli, S. (1996). Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation. Biochem. J. 320, 253-256.
120. Srisailam, S., Wang, H. M., Kumar, T. K., Rajalingam, D., Sivaraja, V., Sheu, H. S., Chang, Y. C. and Yu, C. (2002). Amyloid-like fibril formation in an all beta-barrel protein involves the formation of partially structured intermediate(s). J. Biol. Chem. 277, 19027-19036.
121. Srisailam, S., Kumar, T. K., Rajalingam, D., Kathir, K. M., Shen, H. S., Jan, F. J., Chao, P. C. and Yu, C. (2003). Amyloid-like fibril formation in an all beta-barrel protein. Partially structured intermediate state(s) is a precursor for fibril formation. J. Biol. Chem. 278, 17701-17709.
122. Stylianou, E. and Saklatvala, J. (1998). Interleukin-1. Int. J. Biochem. Cell Biol. 30, 1075-1079.
123. 2-domain proteins that regulate membrane traffic. Neuron 17, 379-388.
124. Szebenyi, G. and Fallon, J. F. (1999). Fibroblast growth factors as multifunctional signaling factors. Int. Rev. Cytol. 185, 45-106.
125. Tanudji, M., Hevi, S. and Chuck, S. L. (2002). Improperly golded green fluorescent protein is secreted via a non-classical pathway. J. Cell Sci. 115, 3849-3857.
126. Tarantini, F., Gamble, S., Jackson, A. and Maciag, T. (1995). The cysteine residue responsible for the release of fibroblast growth factor-1 residues in a domain independent of the domain for phosphatidylserine binding. J. Biol. Chem. 270, 29039-29042.
127. Tarantini, F., LaVallee, T., Jackson, A., Gamble, S., Carreira, C. M., Garfinkel, S., Burgess, W. H. and Maciag, T. (1998). The extravesicular domain of synaptotagmin-1 is released with the latent fibroblast growth factor-1 homodimer in response to heat shock. J. Biol. Chem. 273, 22209-22216.
128. Tarantini, F., Micucci, I., Bellum, S., Landriscina, M., Garfinkel, S., Prudovsky, I. and Maciag, T. (2001). The precursor but not the mature form of IL1alpha blocks the release of FGF1 in response to heat shock. J. Biol. Chem. 276, 5147-5151.
129. Venkataraman, G., Raman, R., Sasisekharan, V. and Sasisekharan, R. (1999). Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. Proc. Natl. Acad. Sci. USA 96, 3658-3663.
130. Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C. A. and Apte, R. N. (2003). IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl. Acad. Sci. USA 100, 2645-2650.
131. Weis, K. (2003). Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell 112, 441-451.
132. Wessendorf, J. H., Garfinkel, S., Zhan, X., Brown, S. and Maciag, T. (1993). Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. J. Biol. Chem. 268, 22100-22104.
133. Wicki, R., Schafer, B. W., Erne, P. and Heizmann, C. W. (1996). Characterization of the human and mouse cDNAs coding for S100A13, a new member of the S100 protein family. Biochem. Biophys. Res. Commun. 227, 594-599.
134. Wiese, A., Gutsmann, T. and Seydel, U. (2003). Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes. J. Endotoxin Res. 9, 67-84.
135. Winkles, J. A., Friesel, R., Burgess, W. H., Howk, R., Mehlman, T., Weinstein, R. and Maciag, T. (1987). Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc. Natl. Acad. Sci. USA 84, 7124-7128.
136. Zavialov, A. V., Berglund, J., Pudney, A. F., Fooks, L. J., Ibrahim, T. M., MacIntyre, S. and Knight, S. D. (2003). Structure and biogenesis of the capsular F1 antigen from Yersinia pestis. Preserved folding energy drives fiber formation. Cell 113, 587-596.
137. Zhang, T., Woods, T. L. and Elder, J. T. (2002). Differential responses of S100A2 to oxidative stress and increased intracellular calcium in normal, immortalized, and malignant human keratinocytes. J. Invest. Dermatol. 119, 1196-1201.
138. Zhu, X., Komiya, H., Chirino, A., Faham, S., Fox, G. M., Arakawa, T., Hsu, B. T. and Rees, D. C. (1991). Three-dimensional structures of acidic and basic fibroblast growth factors. Science 251, 90-93.
139. Zoli, A., Altomonte, L., Caricchio, R., Galossi, A., Mirone, L., Ruffini, M. P. and Magaro, M. (1998). Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1 beta and tumour necrosis factor alpha. Clin. Rheumatol. 17, 378-382.